Transcription of TAMBOCORTM Injection - Medsafe
{{id}} {{{paragraph}}}
Example: bachelor of science
TAMBOCORTM Injection - Medsafe
NEW ZEALAND DATA SHEET. TAMBOCORTM Injection 1 PRODUCT NAME. tambocor 10 mg/mL Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION. Each ampoule contains flecainide acetate 150 mg in acetate buffered Water for Injections BP 15 mL. For the full list of excipients see section 3 PHARMACEUTICAL FORM. Solution for Injection or infusion 4 CLINICAL PARTICULARS. Therapeutic indications tambocor Injection is indicated in patients without structural heart disease when rapid control or short-term prophylaxis of the arrhythmias below is the main clinical requirement, including: ventricular tachyarrhythmias where these are resistant to other treatment;. AV nodal reciprocating tachycardia, arrhythmias associated with Wolff-Parkinson-White Syndrome and similar conditions with accessory pathways;. paroxysmal atrial fibrillation in patients with disabling symptoms.
NEW ZEALAND DATA SHEET TAMBOCORTM Injection TAMBOCOR Page 2 of 15 Dilution of TAMBOCOR injection TAMBOCOR Injection should preferably be diluted with, or injected into, sterile solutions of 5%
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: